Included under terms of UK Non-commercial Government License.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Nyssen OP, Taylor SJC, Wong G, et al. Does therapeutic writing help people with long-term conditions? Systematic review, realist synthesis and economic considerations. Southampton (UK): NIHR Journals Library; 2016 Apr. (Health Technology Assessment, No. 20.27.)
Does therapeutic writing help people with long-term conditions? Systematic review, realist synthesis and economic considerations.
Show detailsSystematic review data extraction forms
Baseline data
TABLE 90
# (reference number in the citation manager) | ||
---|---|---|
Publication details | Author(s) | |
Year | ||
Title | ||
Journal | ||
Volume | ||
Issue | ||
Pages | ||
Format of publication | ||
Study overview | Study name | |
Study objectives | ||
Study overall conclusions | ||
DID TW WORK? | ||
Why does it work? Why not? Who do they think it works for? | ||
Country/region of the study | ||
Time span of the study | ||
Number of sites | ||
Funding | Description of funding (public/private, etc.) | |
Funded? Yes/No | ||
Study moderators and/or mediators | Moderator(s) effect? Including: effect moderators (patients’ characteristics) interacting with the intervention to change outcome – baseline variables that affect outcome but not interact with intervention | |
Mediator(s) effect? Including: change-in-process factors impacting outcome with or without interaction with intervention |
TABLE 91
Study intervention: exposure and comparator | Intervention type(s) | |
Definition | ||
Site of the intervention(s) | ||
Intervention(s) exposure episode and duration | ||
Length of the intervention(s) | ||
Comparator type | ||
Comparator definition | ||
Time of assessment | ||
Concomitant therapies | ||
Intervention fidelity | ||
Intervention credibility or subjective essay evaluation or manipulation checks | ||
Participant(s) type | Target population | LTC category |
LTC type and diagnostic criteria | ||
LTC category | ||
ITT (and PP) sample size | ||
ITT sample size by groups (treatment arms) | ||
Participants selection criteria | Main inclusion criteria | |
Main exclusion criteria | ||
Participants baseline characteristics | Baseline characteristics | Age |
Gender | ||
Ethnicity | ||
Disease status and severity | ||
Comorbidities | ||
Other characteristics |
PP, per protocol.
TABLE 92
Study flow diagram | Study participation [based on Sohanpal et al., www | # participants ELIGIBLE to the study (and # of non-participants) |
# participants RECRUITED (# of study participants willing to take part) | ||
# study participants NON-ATTENDERS (recruited not willing to attend intervention) | ||
# study ATTENDERS (attending at least one session of the intervention) | ||
# study attenders DROPPING OUT (after one session or more) | ||
# programme COMPLETERS (# participants completing all sessions of the intervention) | ||
Study DROP-OUTs (# non-attenders or programme dropouts or programme completers that drop out also from the study) | ||
Recruitment method(s) | ||
---|---|---|
Type(s) of outcome(s) reported (by responding Yes/No) | Outcomes assessed | |
Physical health | Physiological | |
Haematological/immunological/hormonal | ||
Disability/handicap | ||
Pain | ||
Non-physical health | Psychological | |
Social health | ||
Mental status | ||
Behavioural | ||
Performance | ||
HRQoL | ||
Costs/resource use | ||
Safety | ||
Compliance | ||
Other |
Results section
TABLE 93
Physiological outcomes | Description | Selected end point(s) |
Definition(s) and type of outcome | ||
Time of assessment(s) and overall outcome follow-up | ||
Type of analysis | ||
Results | Values | |
Summary of the impact of intervention(s) on patient-reported outcomes | ||
Haematological/immunological outcomes | Description | Selected end point(s) |
Definition(s) | ||
Time of assessment(s) and overall outcome follow-up | ||
Type of analysis | ||
Results | Values | |
Summary of the impact of intervention(s) on patient-reported outcomes | ||
Physical disability/handicap assessment | Description | Selected end point(s) |
Definition(s) | ||
Time of assessment(s) and overall outcome follow-up | ||
Type of analysis | ||
Results | Values | |
Summary of the impact of the intervention | ||
Pain measurement | Description | Selected end point(s) |
Definition(s) | ||
Time of assessment(s) and overall outcome follow-up | ||
Type of analysis | ||
Results | Values | |
Summary of the impact of intervention(s) on patient-reported outcomes | ||
Psychological assessment | Description | Selected end point(s) |
Definition(s) | ||
Time of assessment(s) and overall outcome follow-up | ||
Type of analysis | ||
Results | Values | |
Summary of the impact of intervention(s) on patient-reported outcomes | ||
Social health assessment | Description | Selected end point(s) |
Definition(s) | ||
Time of assessment(s) and overall outcome follow-up | ||
Type of analysis | ||
Results | Values | |
Summary of the impact of intervention(s) on patient-reported outcomes | ||
Mental status assessment | Description | Selected end point(s) |
Definition(s) | ||
Time of assessment(s) and overall outcome follow-up | ||
Type of analysis | ||
Results | Values | |
Summary of the impact of intervention(s) on patient-reported outcomes | ||
Behavioural assessment | Description | Selected end point(s) |
Definition(s) | ||
Time of assessment(s) and overall outcome follow-up | ||
Type of analysis | ||
Results | Values | |
Summary of the impact of intervention(s) on patient-reported outcomes | ||
Performance assessment | Description | Selected end point(s) |
Definition(s) | ||
Time of assessment(s) and overall outcome follow-up | ||
Type of analysis | ||
Results | Values | |
Summary of the impact of intervention(s) on patient-reported outcomes | ||
General health status and quality of life | Description | Instrument(s) type |
Definition | ||
Time of assessment(s) and overall outcome follow-up | ||
Type of analysis | ||
Results | Values | |
Summary of the impact of intervention(s) on patient-reported outcomes | ||
Assessment of adverse events due to intervention (and not related to concomitant therapy) | Description and identification of AEs | Selected end point(s) |
Definition(s)/reported categories of AEs | ||
Time of assessment(s) | ||
Type of analysis | ||
Results | ||
Assessment of compliance (adherence) | Description | Selected end point(s) |
Definition(s) | ||
Time of assessment | ||
Results | ||
Costs and levels of resource use (related to specific intervention) | Resource use | Type |
Analysis | ||
Levels of resource used | ||
Summary of the impact of intervention(s) on resource used | ||
Perspective | ||
Currency | Currency | |
Price year | ||
If inflated, inflator | ||
Time period to which costs relate | ||
Unit cost | ||
Total costs | ||
Specific findings helping programme theory | Theories or mechanisms postulated by study’s authors to explain the success of the intervention | |
Process factors identified by study authors helping the successful theory | ||
Theories or mechanisms postulated by study’s authors to explain the failure(s) of the intervention | ||
Process factors identified by study authors helping the failure of the theory | ||
How study contributes to realist review | ||
Summary of the impact of intervention(s) on patient-reported outcomes | ||
Additional comments to the study (does the study support previous research?) | ||
Correspondence required with authors for missing data? | ||
References not captured by the review (cross-referencing) | ||
Notes |
AE, adverse event.
Realist synthesis data extraction forms
TABLE 94
First author, date | Data to support programme theory included in the systematic review | Primary study author’s explanation for how TW works |
TABLE 95
Recruitment/suitability | Intervention process/aspects of the intervention | Outcomes impact |
---|---|---|
Who is it suitable for and why? | What do you do and why? | What do you hope to achieve and why? |
Quality assessment tools
Clinical trials: Cochrane Handbook for Systematic Reviews of Interventions
TABLE 96
Study design | Trial design | |
---|---|---|
Study quality checklist (based on the checklist in the Cochrane Handbook) | Randomisation | Sequence generation (selection bias) |
Allocation concealment (selection bias) | ||
Blinding | Outcome | |
Performance | ||
ITT analysis? (Yes/No) | ||
Description of outcomes differences between groups (selective reporting) | ||
Description of withdrawals (attrition bias) | ||
Pre-specified criteria for eligibility of patients | ||
Similarity of groups at baseline regarding prognostic factors | ||
Statement supporting the quality of the methods used |
Observational studies: Newcastle–Ottawa checklist
TABLE 97
Study quality checklist | Case–control studies | Selection | Is the case definition adequate? |
Representativeness of the cases | |||
Selection of controls | |||
Definition of controls | |||
Comparability | Comparability of cases and controls on the basis of the design or analysis | ||
Factor(s) | |||
Exposure | Ascertainment of exposure | ||
Same method of ascertainment for cases and controls | |||
Non-response rate | |||
Cohort (and cross-sectional) studies | Selection | Representativeness of the exposed cohort | |
Selection of the non-exposed cohort | |||
Ascertainment of exposure | |||
Demonstration that outcome of interest was not present at start of study | |||
Comparability | Comparability of exposed and unexposed (design or analysis) | ||
Factor(s) | |||
Outcome | Assessment of outcome | ||
Was follow-up long enough for outcome to occur | |||
Adequacy of follow-up |
- Data extraction form and quality assessment methods used - Does therapeutic writ...Data extraction form and quality assessment methods used - Does therapeutic writing help people with long-term conditions? Systematic review, realist synthesis and economic considerations
Your browsing activity is empty.
Activity recording is turned off.
See more...